Publication

Negative symptoms in individuals at clinical high risk of psychosis

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Danijela Piskulic, University of CalgaryJean Addington, University of CalgaryKristin S. Cadenhead, University of California at San DiegoTyrone D. Cannon, University of California Los AngelesBarbara A. Cornblatt, Zucker Hillside HospitalRobert Heinssen, National Institutes of HealthDiana O. Perkins, University of North CarolinaLarry J. Seidman, Harvard Medical SchoolMing T. Tsuang, University of California at San DiegoElaine Walker, Emory UniversityScott W. Woods, Yale UniversityThomas H. McGlashan, Yale University
Language
  • English
Date
  • 2012-04
Publisher
  • Elsevier: 12 months
Publication Version
Copyright Statement
  • © 2012 Elsevier Ireland Ltd. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0165-1781
Volume
  • 196
Issue
  • 2-3
Start Page
  • 220
End Page
  • 224
Grant/Funding Information
  • This work was supported by the National Institute of Mental Health {grant numbers U01 MH066160 to SWW, U01 MH066134 to JA, R01 MH60720 and K24 MH76191 to KSC, R01 MH065079 to TDC, R01 MH061523 to BAC, R01 MH066069 and K23 MH01905to DOP, R18 MH 43518 (MTT and LJS), R01 MH065562 and P50 MH080272 to LJS, R21MH075027 to MTT, RO1MH062066 to EFW, K05MH01654 to THM]; Donaghue Foundation {to SWW]; and Eli Lilly & Co {to THM, JA, and DOP].
Supplemental Material (URL)
Abstract
  • Negative symptoms are present in the psychosis prodrome. However, the extent to which these symptoms are present prior to the onset of the first episode of psychosis remains under-researched. The goal of this study is to examine negative symptoms in a sample of individuals at clinical high risk (CHR) for psychosis and to determine if they are predictive of conversion to psychosis. Participants (n=138) were all participants in the North American Prodrome Longitudinal Study (NAPLS 1) project. Negative symptoms were assessed longitudinally using the Scale of Prodromal Symptoms. The mean total negative symptom score at baseline was 11.0, with 82.0% of the sample scoring at moderate severity or above on at least one negative symptom. Over the course of 12 months, the symptoms remained in the above moderate severity range for 54.0% of participants. Associations between individual symptoms were moderate (r= 0.31 to r= 0.57, P<0.001) and a factor analysis confirmed that all negative symptoms loaded heavily on one factor. Negative symptoms were more severe and persistent over-time in those who converted to psychosis, predicting the likelihood of conversion (χ2 = 17.63, df= 6, P< 0.01, R2 = 0.21). Thus, early and persistent negative symptoms may represent a vulnerability for risk of developing psychosis.
Author Notes
  • Danijela Piskulic, Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Mental Health Centre for Research and Education, 3280 Hospital Drive NW, Calgary, Alberta T2N 4Z6 Canada. Email: dpiskuli@ucalgary.ca.
Keywords
Research Categories
  • Psychology, Behavioral
  • Psychology, General

Tools

Relations

In Collection:

Items